Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AirGenics appears to be a U.S.-based cylinder requalification and refurbishment company serving the packaged gas industry, with operations in Newark, New Jersey. During the COVID-19 pandemic, the company was reported to have converted inert gas cylinders into medical oxygen cylinders to help address emergency oxygen supply needs in the United States. Its business is not a drug-development biotech model; rather, it operates as an industrial and medical-gas infrastructure provider adjacent to healthcare. Available public information suggests its core capabilities center on compressed gas cylinder testing, refurbishment, maintenance, and preparation for medical oxygen use. For a biotech analyst, AirGenics is best understood as a commercial medical-gas services company rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AirGenics.